These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36438599)

  • 1. Prognostic pyroptosis-related lncRNA signature predicts the efficacy of immunotherapy in hepatocellular carcinoma.
    Cheng Z; Han J; Jiang F; Chen W; Ma X
    Biochem Biophys Rep; 2022 Dec; 32():101389. PubMed ID: 36438599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Pyroptosis-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immunotherapeutic Efficiency in Hepatocellular Carcinoma.
    Wang T; Yang Y; Sun T; Qiu H; Wang J; Ding C; Lan R; He Q; Wang W
    Front Cell Dev Biol; 2022; 10():779269. PubMed ID: 35712653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Analysis of the Correlation Between Pyroptosis-Related LncRNAs and Tumor Microenvironment, Prognosis, and Immune Infiltration in Hepatocellular Carcinoma.
    Qu G; Wang D; Xu W; Guo W
    Front Genet; 2022; 13():867627. PubMed ID: 35559014
    [No Abstract]   [Full Text] [Related]  

  • 4. Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma.
    Liu ZK; Wu KF; Zhang RY; Kong LM; Shang RZ; Lv JJ; Li C; Lu M; Yong YL; Zhang C; Zheng NS; Li YH; Chen ZN; Bian H; Wei D
    Front Oncol; 2022; 12():794034. PubMed ID: 35311105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of an Immune-Related Six-lncRNA Signature to Predict the Outcomes, Immune Cell Infiltration, and Immunotherapy Response in Patients With Hepatocellular Carcinoma.
    Zhou P; Lu Y; Zhang Y; Wang L
    Front Oncol; 2021; 11():661758. PubMed ID: 34277410
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Zhang L; Zhang X; Zhao W; Xiao X; Liu S; Peng Q; Jiang N; Zhou B
    Front Med (Lausanne); 2022; 9():760722. PubMed ID: 35308537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients.
    Huang S; Li D; Zhuang L; Zhang J; Wu J
    Front Med (Lausanne); 2022; 9():850343. PubMed ID: 35685422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA-based signature for predicting prognosis of hepatocellular carcinoma.
    Cao J; Wu L; Lei X; Shi K; Shi L; Shi Y
    Bioengineered; 2021 Dec; 12(1):673-681. PubMed ID: 33622186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A somatic mutation-derived LncRNA signatures of genomic instability predicts the prognosis and tumor microenvironment immune characters in hepatocellular carcinoma.
    Jin C; Zhao JS; Huang XQ; Yang XZ; Niu FY; Lin JR; Ma L; Shi YX; Li XS; Jiang P; Gao S; Li F; Song Y
    Hepatol Int; 2022 Oct; 16(5):1220-1233. PubMed ID: 35947245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory Response-Related Long Non-Coding RNA Signature Predicts the Prognosis of Hepatocellular Carcinoma.
    Li X; Zhang S; Zhang S; Kuang W; Tang C
    J Oncol; 2022; 2022():9917244. PubMed ID: 35342418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pyroptosis-related gene signature predicts prognosis and immune microenvironment in hepatocellular carcinoma.
    Jin Y; Pu X; Ping D; Huang C; Ding G; Cao L
    World J Surg Oncol; 2022 Jun; 20(1):179. PubMed ID: 35659304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying a Hypoxia-Related Long Non-Coding RNAs Signature to Improve the Prediction of Prognosis and Immunotherapy Response in Hepatocellular Carcinoma.
    Tang P; Qu W; Wang T; Liu M; Wu D; Tan L; Zhou H
    Front Genet; 2021; 12():785185. PubMed ID: 34917132
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of Novel Tumor Microenvironment-Related Long Noncoding RNAs to Determine the Prognosis and Response to Immunotherapy of Hepatocellular Carcinoma Patients.
    Huang S; Zhang J; Lai X; Zhuang L; Wu J
    Front Mol Biosci; 2021; 8():781307. PubMed ID: 35004851
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma.
    Wang X; Qian J; Yao N; Pocha C; Kang KJ; Angelico R; Zhu G
    Ann Transl Med; 2022 May; 10(10):595. PubMed ID: 35722420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis and Tumour Immune Microenvironment of Patients With Hepatocellular Carcinoma by a Novel Pyroptosis-Related lncRNA Signature.
    Zhang Z; Shang J; Hu B; Shi H; Cao Y; Li J; Jiao T; Zhang W; Lu S
    Front Immunol; 2022; 13():836576. PubMed ID: 35812396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyroptosis-Related Risk Signature Exhibits Distinct Prognostic, Immune, and Therapeutic Landscapes in Hepatocellular Carcinoma.
    Zhao Y; Song Q; Xu F; Zhou Y; Zuo X; Zhang Z
    Front Genet; 2022; 13():823443. PubMed ID: 35368686
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification and validation of a novel pyroptosis-related lncRNAs signature associated with prognosis and immune regulation of hepatocellular carcinoma.
    Zhang Z; Xia F; Xu Z; Peng J; Kang F; Li J; Zhang W; Hong Q
    Sci Rep; 2022 May; 12(1):8886. PubMed ID: 35614201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of an Immune-Related lncRNA Signature for Predicting the Prognosis of Hepatocellular Carcinoma.
    Kong W; Wang X; Zuo X; Mao Z; Cheng Y; Chen W
    Front Genet; 2020; 11():1037. PubMed ID: 33101369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.